These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35814246)

  • 1. Profiling COVID-19 Vaccine Adverse Events by Statistical and Ontological Analysis of VAERS Case Reports.
    Guo W; Deguise J; Tian Y; Huang PC; Goru R; Yang Q; Peng S; Zhang L; Zhao L; Xie J; He Y
    Front Pharmacol; 2022; 13():870599. PubMed ID: 35814246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of COVID-19 vaccine-induced myocarditis.
    Rose J; Hulscher N; McCullough PA
    Ther Adv Drug Saf; 2024; 15():20420986241226566. PubMed ID: 38293564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Comparison of Adverse Events of Coronavirus Disease 2019 Vaccines Reported to the United States Vaccine Adverse Event Reporting System Between 14 December 2020 and 8 October 2021.
    Zou C; Xue X; Qian J
    Front Med (Lausanne); 2022; 9():826327. PubMed ID: 35449806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.
    Woo EJ; Gee J; Marquez P; Baggs J; Abara WE; McNeil MM; Dimova RB; Su JR
    Vaccine; 2023 Jul; 41(30):4422-4430. PubMed ID: 37321898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparability of clinical trials and spontaneous reporting data regarding COVID-19 vaccine safety.
    Luo C; Du J; Cuker A; Lautenbach E; Asch DA; Poland GA; Tao C; Chen Y
    Sci Rep; 2022 Jun; 12(1):10946. PubMed ID: 35768434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cov19VaxKB: A Web-based Integrative COVID-19 Vaccine Knowledge Base.
    Huang PC; Goru R; Huffman A; Yu Lin A; Cooke MF; He Y
    Vaccine X; 2021 Dec; 10():100139. PubMed ID: 34981039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
    Jacobs JW; Booth GS; Adkins BD
    Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OAE-based data mining and modeling analysis of adverse events associated with three licensed HPV vaccines.
    Zi W; Yang Q; Su J; He Y; Xie J
    Heliyon; 2022 Nov; 8(11):e11515. PubMed ID: 36411908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Events of COVID-19 Vaccines in the United States: Temporal and Spatial Analysis.
    Li Y; Li J; Dang Y; Chen Y; Tao C
    JMIR Public Health Surveill; 2024 Jul; 10():e51007. PubMed ID: 39008362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines.
    Flora J; Khan W; Jin J; Jin D; Hussain A; Dajani K; Khan B
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.
    Sarntivijai S; Xiang Z; Shedden KA; Markel H; Omenn GS; Athey BD; He Y
    PLoS One; 2012; 7(11):e49941. PubMed ID: 23209624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    Xie J; Codd C; Mo K; He Y
    PLoS One; 2016; 11(10):e0164792. PubMed ID: 27749923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.
    Gee J; Marquez P; Su J; Calvert GM; Liu R; Myers T; Nair N; Martin S; Clark T; Markowitz L; Lindsey N; Zhang B; Licata C; Jazwa A; Sotir M; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(8):283-288. PubMed ID: 33630816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data.
    Sa S; Lee CW; Shim SR; Yoo H; Choi J; Kim JH; Lee K; Hong M; Han HW
    Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Simultaneous Administration of Bivalent mRNA COVID-19 and Influenza Vaccines in the Vaccine Adverse Event Reporting System (VAERS).
    Moro PL; Ennulat C; Brown H; Woody G; Zhang B; Marquez P; Woo EJ; Su JR
    Drug Saf; 2024 May; 47(5):487-493. PubMed ID: 38411838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.